透景生命(300642) - 2023 Q1 - 季度财报

Financial Performance - The company's revenue for Q1 2023 was ¥121,844,833.48, a decrease of 16.03% compared to ¥145,099,766.40 in the same period last year[3] - Net profit attributable to shareholders increased by 111.17% to ¥11,129,200.78 from ¥5,270,134.33 year-on-year[3] - The net profit excluding non-recurring gains and losses rose by 207.79% to ¥9,434,141.08 from ¥3,065,114.09 in the previous year[3] - Basic earnings per share increased by 110.80% to ¥0.0683 from ¥0.0324 in the same period last year[3] - Total operating revenue for Q1 2023 was CNY 121,844,833.48, a decrease of 16.04% compared to CNY 145,099,766.40 in the same period last year[21] - Net profit for Q1 2023 reached CNY 10,465,770.51, an increase of 99.00% compared to CNY 5,242,502.79 in Q1 2022[23] - The total comprehensive income attributable to the parent company reached ¥11,129,200.78, a significant increase from ¥5,270,134.33 in the previous period, representing a growth of approximately 111.5%[24] - Basic earnings per share increased to ¥0.0683 from ¥0.0324, reflecting a growth of 111.1% year-over-year[24] Cash Flow and Assets - The net cash flow from operating activities was negative at -¥2,017,596.63, a decline of 102.90% compared to ¥69,670,388.41 in the previous year[3] - Cash inflow from operating activities totaled ¥130,566,248.79, down 32.9% from ¥194,746,627.61 in the prior period[26] - Cash outflow from operating activities increased to ¥132,583,845.42, compared to ¥125,076,239.20 in the previous period, marking an increase of 6.4%[26] - Cash flow from investing activities generated a net inflow of ¥9,176,923.09, down from ¥58,012,186.31 in the previous period, indicating a decrease of 84.2%[27] - The company reported cash and cash equivalents at the end of the period amounting to ¥263,674,946.15, down from ¥307,162,432.92 in the previous period, a decrease of 14.1%[27] - The company's cash and cash equivalents increased to CNY 263,934,030.25 from CNY 243,484,642.21 at the beginning of the year, reflecting a growth of 8.99%[18] - Total assets at the end of Q1 2023 were ¥1,648,539,962.01, a decrease of 0.97% from ¥1,664,722,687.00 at the end of the previous year[3] - Total liabilities decreased to CNY 153,798,531.52 from CNY 184,073,131.32, a reduction of 16.43%[20] Shareholder Information - The total number of common shareholders at the end of the reporting period is 16,102[11] - The largest shareholder, Yao Jian'er, holds 19.93% of shares, totaling 32,753,700 shares, with 24,565,275 shares pledged[11] - Lingfei Group Limited holds 7.32% of shares, totaling 12,035,800 shares, with 8,580,000 shares pledged[11] - The total number of shares held by the top ten unrestricted shareholders includes UBS AG with 5.03% (8,271,877 shares) and Merrill Lynch International with 3.72% (6,122,677 shares)[12] - The total number of shares held by the top ten shareholders represents a significant concentration of ownership, with the top three shareholders holding over 32% combined[11] Stock Incentive Plan - The company completed the grant and registration of 1.61 million restricted shares and 4.78 million stock options under the 2023 stock option and restricted stock incentive plan[16] - The total number of restricted shares at the end of the period is 26,674,775 shares, with no shares released during the reporting period[15] - The company adjusted performance assessment targets in the stock incentive plan to enhance operational feasibility and challenge[16] - The company has a total of 445,500 other restricted shares, with 1,530,000 shares added during the reporting period[15] - The company’s core team stability and employee motivation are prioritized through the revised stock incentive plans[16] Tax and Other Financial Metrics - The company experienced a 41.57% decrease in taxes and surcharges, amounting to ¥1,425,628.71, due to reduced revenue and profit[9] - The company reported an investment income of ¥8,555,652.76, a significant increase of 253.27% compared to ¥2,421,856.89 in the previous year[9] - The net cash flow from financing activities increased by 318.13% to ¥14,208,736.62, primarily due to received equity incentive subscription payments[9] - The company experienced a foreign exchange loss of ¥918,675.04, compared to a loss of ¥218,346.10 in the previous period[27]